TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32690516

Group type: EXPERIMENTAL
Intervention: HIVST plus standard facility-based counselling and testing from 0 to 12 months
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard facility-based counselling and testing from 0 to 6 months, then crossover to receive the HIVST intervention in months 7-12
Number of subjects: 1000
Study: 36137841

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy combined with surgery (NCRT group)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Surgery alone (S group)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: NCRT
Number of subjects: 451
Study: 34322621

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) sessions, practice at home, and recorded sound
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 36064643

Group type: EXPERIMENTAL
Intervention: OnTrackChile (OTCH) program
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care services
Number of subjects: 300
Study: 34874418

Group type: EXPERIMENTAL
Intervention: YEARS rule combined with age-adjusted D-dimer threshold (D-dimer <1000 ng/mL or <500 ng/mL for age <50 years or age in years × 10 for patients ≥50 years)
Number of subjects: 1414

Group type: COMPARATOR
Intervention: Control group with age-adjusted D-dimer threshold
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: YEARS rule
Number of subjects: 1414
Study: 35188677

Group type: EXPERIMENTAL
Intervention: 10Hz rTMS
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: iTBS
Number of subjects: 162
Study: 34790521

Group type: EXPERIMENTAL
Intervention: 1-L PEG
Number of subjects: 852

Group type: COMPARATOR
Intervention: 2-L PEG
Number of subjects: 852
Study: 33315813

Group type: EXPERIMENTAL
Intervention: Euglycemic group (BG >3.9 to ≤10.0 mmol�L‐1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hyperglycemic group (BG >10.0 mmol�L‐1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Both groups (comparison)
Number of subjects: 36
Study: 36207872

Group type: EXPERIMENTAL
Intervention: Nomogram model based on clinical data and radiomics
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 136

Group type: COMPARATOR
Intervention: Radscore of EBV positive group
Number of subjects: 136
Study: 33941737

Group type: EXPERIMENTAL
Intervention: Legacy intervention (group-based positive parenting interventions)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Comparison group (mothers who did not participate in the intervention)
Number of subjects: 364
Study: 32384509

Group type: EXPERIMENTAL
Intervention: Chinese herbal bath (various temperatures and concentrations)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Ozone hydrotherapy
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Basic treatment (co‐qingdai capsule, compound glycyrrhizin tablet, AA Skincare jojoba Oil)
Number of subjects: 288
Study: 35589616

Group type: EXPERIMENTAL
Intervention: Tirzepatide 10 mg
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Tirzepatide 15 mg
Number of subjects: 238

Group type: COMPARATOR
Intervention: Tirzepatide 5 mg
Number of subjects: 238
Study: 32675334

Group type: EXPERIMENTAL
Intervention: Educational statement on CPOX harms
Number of subjects: 357

Group type: COMPARATOR
Intervention: Standard CPOX monitoring
Number of subjects: 357
Study: 35634931

Group type: EXPERIMENTAL
Intervention: IAT (conventional-dose cytarabine, idarubicin, and thioguanine)
Number of subjects: 356

Group type: COMPARATOR
Intervention: IdAraC-Ida (intermediate-dose cytarabine and idarubicin)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Risk classification and measurable residual disease (MRD) assessment
Number of subjects: 356
Study: 33986030

Group type: EXPERIMENTAL
Intervention: Eliapixant 750 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Eliapixant ≥50 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Eliapixant (all doses)
Number of subjects: 40
Study: 35432581

Group type: EXPERIMENTAL
Intervention: Insomnia patients with more dreams
Number of subjects: 72
Study: 32394478

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) - 2000 shocks, frequency of 3 Hz, maximum total energy flow density 0.25 mJ/mm2, once a week for 4 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo - shock wave setting without energy transmission
Number of subjects: 54
Study: 34839332

Group type: EXPERIMENTAL
Intervention: Antibody-drug conjugates (ADCs)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Off drug (3-month follow-up)
Number of subjects: 29
Study: 34115736

Group type: EXPERIMENTAL
Intervention: Auricular Acupressure (AA) on low back pain-related points, 6 weeks duration
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo Auricular Acupressure on points unrelated to low back pain, 6 weeks duration
Number of subjects: 51
Study: 32345594

Group type: EXPERIMENTAL
Intervention: Patients with cancer
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Patients who received surgery
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Patients who underwent only radiotherapy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Nonmetastatic cancer patients
Number of subjects: 105
Study: 34490685

Group type: EXPERIMENTAL
Intervention: Phantom limb pain (PLP) group
Number of subjects: 107

Group type: COMPARATOR
Intervention: Pain-Free peers with LLL
Number of subjects: 107

Group type: COMPARATOR
Intervention: Controls with intact limbs
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Adults with PLP
Number of subjects: 107
Study: 32567518

Group type: EXPERIMENTAL
Intervention: Meetings with a peer mentor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Organ donation mailings
Number of subjects: 0
Study: 32472048

Group type: EXPERIMENTAL
Intervention: Conbercept combined with panretinal photocoagulation (PRP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP) alone
Number of subjects: 15
Study: 34631030

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone (12 mg once daily or 12 mg once every other day; oral methylnaltrexone 150, 300, or 450 mg daily)
Number of subjects: 1263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1263

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone
Number of subjects: 1263
Study: 32468267

Group type: EXPERIMENTAL
Intervention: Endometrial scratching (ES) in the luteal phase of the cycle preceding the embryo transfer cycle (group A)
Number of subjects: 352

Group type: COMPARATOR
Intervention: No intervention (group B)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Endometrial scratching (ES)
Number of subjects: 352
Study: 35323856

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with TPC (paclitaxel, cisplatin, capecitabine)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Induction chemotherapy with PF (cisplatin, fluorouracil)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with TPC
Number of subjects: 238
Study: 35725639

Group type: EXPERIMENTAL
Intervention: Fuling-Zexie decoction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33780091

Group type: EXPERIMENTAL
Intervention: Improved epidural tunneling technique (group I)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control tunneling technique (group C)
Number of subjects: 20
Study: 32847735

Group type: COMPARATOR
Intervention: Health care provider frequently discussed weight
Number of subjects: 2811

Group type: COMPARATOR
Intervention: Perceived as normal weight or underweight
Number of subjects: 2811

Group type: COMPARATOR
Intervention: Never tried to lose at least 10 lbs, ate 0−2 servings of fruits and vegetables daily, or engaged in 0−29 min of physical activity weekly
Number of subjects: 2811
Study: 33443017

Group type: EXPERIMENTAL
Intervention: Colon Capsule Endoscopy (CCE)
Number of subjects: 286

Group type: COMPARATOR
Intervention: CT Colonography (CTC)
Number of subjects: 286
Study: 32527192

Group type: EXPERIMENTAL
Intervention: Intensified loading strategy (ILS) with prasugrel 60 mg
Number of subjects: 781

Group type: COMPARATOR
Intervention: Standard loading strategy with clopidogrel 600 mg
Number of subjects: 781
Study: 35796097

Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride (CPC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Four different antiseptic mouthwashes
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 33906086

Group type: EXPERIMENTAL
Intervention: Abemaciclib (150 mg twice daily) + fulvestrant/NSAI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abemaciclib
Number of subjects: 0
Study: 34240656

Group type: EXPERIMENTAL
Intervention: Temelimab 18 mg/kg
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 34887867

Group type: EXPERIMENTAL
Intervention: AZ vaccination
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: mRNA vaccination
Number of subjects: 80
Study: 33559090

Group type: EXPERIMENTAL
Intervention: AEA group (antofloxacin 200 mg once daily, esomeprazole 20 mg + amoxicillin 1000 mg twice daily for 14 days)
Number of subjects: 196
Study: 32690743

Group type: EXPERIMENTAL
Intervention: Wool-derived keratin dressing
Number of subjects: 143

Group type: COMPARATOR
Intervention: Usual care dressings
Number of subjects: 143
Study: 35637753

Group type: EXPERIMENTAL
Intervention: Platform-switched (PS) abutments
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nonplatform-switched (NPS) abutments
Number of subjects: 27
Study: 34029860

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Face-to-Face (F2F)
Number of subjects: 41
Study: 34984845

Group type: EXPERIMENTAL
Intervention: Normoxia
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hypoxia (12% O2)
Number of subjects: 8
Study: 34628742

Group type: EXPERIMENTAL
Intervention: Acupuncture and medication group 1 (2 Hz continuous wave)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Acupuncture and medication group 2 (50 Hz continuous wave)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Acupuncture and medication group 3 (2 Hz/50 Hz disperse-dense wave)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Medication group (conventional medication)
Number of subjects: 118
Study: 33093030

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccination
Number of subjects: 24000

Group type: EXPERIMENTAL
Intervention: MenB-fHbp vaccination
Number of subjects: 24000

Group type: COMPARATOR
Intervention: Control group (no vaccination initially)
Number of subjects: 24000

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccination (after 12 months for control group)
Number of subjects: 24000

Group type: EXPERIMENTAL
Intervention: 4CMenB and MenB-fHbp vaccinations
Number of subjects: 24000
Study: 36206044

Group type: EXPERIMENTAL
Intervention: SOVA intervention (peer support website)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 146
Study: 32652065

Group type: EXPERIMENTAL
Intervention: Single-unit protocol (1 unit of packed red blood cells)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Multiple-unit protocol (2 units of packed red blood cells)
Number of subjects: 66
Study: 34414814

Group type: EXPERIMENTAL
Intervention: Joint mobilization and therapeutic exercises (physical therapy group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (booklet only)
Number of subjects: 24
Study: 33992570

Group type: EXPERIMENTAL
Intervention: CRT-D (Cardiac Resynchronization Therapy with Defibrillator)
Number of subjects: 555

Group type: COMPARATOR
Intervention: CRT-P (Cardiac Resynchronization Therapy without Defibrillator)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 555

Group type: COMPARATOR
Intervention: CRT-D and CRT-P
Number of subjects: 555
Study: 32638392

Group type: EXPERIMENTAL
Intervention: Shaving
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plucking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Waxing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 0
Study: 35550459

Group type: EXPERIMENTAL
Intervention: Supraglottic airway device (SAD) general anesthesia
Number of subjects: 116

Group type: COMPARATOR
Intervention: Endotracheal intubation (EI) general anesthesia
Number of subjects: 116
Study: 33862308

Group type: EXPERIMENTAL
Intervention: SBR boot condition
Number of subjects: 24

Group type: COMPARATOR
Intervention: PU boot condition
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Loaded walking (15-kg backpack)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Loaded walking (no backpack)
Number of subjects: 24
Study: 32896992

Group type: EXPERIMENTAL
Intervention: Single-dose regimen of methotrexate (MTX)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Triple-dose regimen of methotrexate (MTX)
Number of subjects: 89
Study: 35148577

Group type: EXPERIMENTAL
Intervention: Thoracic duct ligation
Number of subjects: 69

Group type: COMPARATOR
Intervention: Non-ligation (control group)
Number of subjects: 69
Study: 36153501

Group type: EXPERIMENTAL
Intervention: Personal protection package consisting of long-lasting insecticidal hammock net, insect repellent, and health communication pamphlet.
Number of subjects: 488

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 488
Study: 34708785

Group type: EXPERIMENTAL
Intervention: Dexamethasone group (DEX)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard of care (SOC) group
Number of subjects: 151
Study: 32500733

Group type: EXPERIMENTAL
Intervention: 1% dilution of lavender scent for 2 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Nonscent for 2 weeks
Number of subjects: 58
Study: 35263547

Group type: EXPERIMENTAL
Intervention: Alcohol-based sanitiser (AS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Capric acid-based sanitiser (CS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Any hand sanitiser
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutralisers in agar
Number of subjects: 0
Study: 33574371

Group type: EXPERIMENTAL
Intervention: Pomegranate juice (8 oz daily)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo juice
Number of subjects: 99
Study: 32971350

Group type: EXPERIMENTAL
Intervention: Active monitoring for low-risk DCIS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 26
Study: 35144303

Group type: EXPERIMENTAL
Intervention: Femoral triangle block (FTB) and interspace between the popliteal artery and the capsule of the posterior knee (IPACK)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intra-articular cocktail analgesic mixture local injection
Number of subjects: 40
Study: 34635855

Group type: EXPERIMENTAL
Intervention: PF‐05221304 2 mg QD
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: PF‐05221304 10 mg QD
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: PF‐05221304 25 mg QD
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: PF‐05221304 50 mg QD
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: PF‐05221304 (15 mg BID) + PF‐06865571 (300 mg BID)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: PF‐05221304 alone
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: PF‐06865571 alone
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: PF‐05221304 (any dose)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: PF‐05221304 + PF‐06865571
Number of subjects: 305
Study: 32990311

Group type: EXPERIMENTAL
Intervention: Physical therapy visits (number and timing)
Number of subjects: 326
Study: 32675019

Group type: EXPERIMENTAL
Intervention: 52 mL/day EVOO
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: DieTBra
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: DieTBra + 52 mL/day EVOO
Number of subjects: 129
Study: 35780807

Group type: EXPERIMENTAL
Intervention: Odevixibat 40 μg/kg per day
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Odevixibat 120 μg/kg per day
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combined odevixibat group (40 μg/kg and 120 μg/kg)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 32894637

Group type: EXPERIMENTAL
Intervention: Early combination therapy (metformin plus vildagliptin)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Metformin monotherapy
Number of subjects: 186
Study: 32416495

Group type: EXPERIMENTAL
Intervention: Future Specificity Training (FeST)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list
Number of subjects: 60
Study: 36460003

Group type: EXPERIMENTAL
Intervention: Variable‐resistance complex training (VRCT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Traditional complex training (TCT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 33580585

Group type: EXPERIMENTAL
Intervention: Postural lung recruitment maneuver
Number of subjects: 84

Group type: COMPARATOR
Intervention: Supine position recruitment maneuver (Control)
Number of subjects: 84
Study: 32590334

Group type: EXPERIMENTAL
Intervention: Children with DCD
Number of subjects: 35

Group type: COMPARATOR
Intervention: Typically-developing children
Number of subjects: 35
Study: 35852694

Group type: EXPERIMENTAL
Intervention: Test cream (steroid + synthetic pseudo‐ceramide), applied twice daily for 2 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control cream (steroid without pseudo‐ceramide), applied twice daily for 2 weeks
Number of subjects: 34
Study: 32467099

Group type: EXPERIMENTAL
Intervention: Second-line docetaxel
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: First-line platinum-based chemotherapy
Number of subjects: 120
Study: 36169608

Group type: EXPERIMENTAL
Intervention: Isotope phosphorus-32 dressing combined with diprospan and mucopolysaccharide polysulphate cream
Number of subjects: 80

Group type: COMPARATOR
Intervention: Diprospan combined with mucopolysaccharide polysulphate cream
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isotopic phosphorus-32 dressing combined with mucopolysaccharide polysulphate cream
Number of subjects: 80
Study: 34521166

Group type: EXPERIMENTAL
Intervention: Bioabsorbable steroid-eluting sinus stent in one frontal sinus ostium (FSO)
Number of subjects: 31
Study: 35305325

Group type: EXPERIMENTAL
Intervention: E-cigarette product placement in music videos (treatment group)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control group (music videos with e-cigarette product placement and imagery digitally removed)
Number of subjects: 303
Study: 34350385

Group type: EXPERIMENTAL
Intervention: Volasertib (350 mg intravenous on days 1 and 15 in 4‐wk cycles) combined with low‐dose cytarabine (LDAC; 20 mg subcutaneous, twice daily, days 1‐10)
Number of subjects: 666

Group type: COMPARATOR
Intervention: LDAC plus placebo
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Volasertib (V) plus low‐dose cytarabine (LDAC)
Number of subjects: 666

Group type: COMPARATOR
Intervention: LDAC plus placebo (P)
Number of subjects: 666
Study: 35584873

Group type: EXPERIMENTAL
Intervention: Functional Imagery Training (FIT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 90
Study: 34166373

Group type: EXPERIMENTAL
Intervention: Single ultrasound-guided hyaluronic acid injection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Extracorporeal shockwave therapy (ESWT)
Number of subjects: 80
Study: 32746194

Group type: EXPERIMENTAL
Intervention: rSVD‐CFWI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SVD‐CFWI
Number of subjects: 0

Group type: COMPARATOR
Intervention: BW‐CFWI
Number of subjects: 0

Group type: COMPARATOR
Intervention: NCC‐BM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rSVD‐CFWI and SVD‐CFWI
Number of subjects: 0
Study: 35646743

Group type: EXPERIMENTAL
Intervention: Fufang Furong Effervescent Suppository
Number of subjects: 80

Group type: COMPARATOR
Intervention: Clindamycin
Number of subjects: 80
Study: 33796883

Group type: EXPERIMENTAL
Intervention: Lateral calcaneal lengthening (LCL)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Subtalar arthroereisis (SA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Comparison of both interventions
Number of subjects: 66
Study: 34707777

Group type: EXPERIMENTAL
Intervention: Melatonin 25 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 33106174

Group type: EXPERIMENTAL
Intervention: non-invasive cervical VNS (nVNS) for 5 days in addition to standard treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: standard treatment alone
Number of subjects: 150
Study: 36317453

Group type: EXPERIMENTAL
Intervention: Esophageal warming (42°C) using recirculated water through a multilumen, silicone tube (EnsoETM®; Attune Medical)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Luminal single-electrode esophageal temperature monitoring probe (LET)
Number of subjects: 42
Study: 32236941

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch
Number of subjects: 5087

Group type: EXPERIMENTAL
Intervention: Lower haemoglobin threshold for transfusion
Number of subjects: 5087

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 5087
Study: 33270254

Group type: EXPERIMENTAL
Intervention: Caregiver education program participation
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Online development evaluations
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: In-home sessions
Number of subjects: 310
Study: 35899585

Group type: EXPERIMENTAL
Intervention: Lateral nasal wall collapse (measured by LNWT area ratio)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no nasal obstruction)
Number of subjects: 24
Study: 34115646

Group type: EXPERIMENTAL
Intervention: Participation in Group Integrated Savings for Health Empowerment (GISHE) microfinance group
Number of subjects: 3609

Group type: COMPARATOR
Intervention: Not participating in GISHE microfinance group
Number of subjects: 3609
Study: 32215899

Group type: EXPERIMENTAL
Intervention: Iomeprol 400 mg/ml (group A)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Iomeprol 300 mg/ml (group B)
Number of subjects: 253
Study: 35103366

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intralesional injection of tuberculin PPD
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cryotherapy plus intralesional injection of tuberculin PPD
Number of subjects: 75
Study: 33429306

Group type: EXPERIMENTAL
Intervention: Nonword repetition tasks (3 tasks with varying complexity)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Scoring based on phonemes produced correctly
Number of subjects: 60